Efficacy and Safety of Doxepin 3 and 6 mg in a 35-day Sleep Laboratory Trial in Adults with Chronic Primary Insomnia

STUDY OBJECTIVES: To evaluate the efficacy and safety of doxepin (DXP) 3 mg and 6 mg in adults diagnosed with primary insomnia. DESIGN AND METHODS: The study was a randomized, double-blind, parallel-group, placebo-controlled trial. Patients meeting DSM-IV-TR criteria for primary insomnia were random...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Krystal, Andrew D., Lankford, Alan, Durrence, H. Heith, Ludington, Elizabeth, Jochelson, Philip, Rogowski, Roberta, Roth, Thomas
Formato: Artigo
Idioma:Inglês
Publicado em: Associated Professional Sleep Societies, LLC 2011
Assuntos:
Efficacy and Safety of Doxepin in Adults with Chronic Insomnia
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3174845/
https://ncbi.nlm.nih.gov/pubmed/21966075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5665/SLEEP.1294
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados